Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis

CONCLUSION: Bimekizumab had a significant clinical benefit in managing PsA and an acceptable safety profile.PMID:38646719 | DOI:10.1080/14740338.2024.2343017

Source: Expert Opinion on Drug Safety - April 22, 2024 Category: Drugs & Pharmacology Authors: Qin-Yi Su Liu Yang Ting-Yu Cao Hai-Ying Dang Zhuo-Chen Han Jia-Jing Cao He-Yi Zhang Ting Cheng Sheng-Xiao Zhang Yue-Hong Huo Source Type: research